Pancreatic Cancer Research

ResearcherThe University of Texas at San Antonio Health Science CenterActive in the last 2 years

Deepika Singh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2407-451X; OpenAlex author ID A5045787586. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Targeting DDR2 for Treating Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-24-1226↗
  2. Nimbolide-encapsulated PLGA nanoparticles induces Mesenchymal-to-Epithelial Transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells. Co-author DOI 10.1016/j.tiv.2021.105293↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chris T.P. Do · 1 shared paper, 2025 · strength 0.19
  2. Manjeet K. Rao · 1 shared paper, 2025 · strength 0.19
  3. Pei Wang · 1 shared paper, 2025 · strength 0.19
  4. Daohong Zhou · 1 shared paper, 2025 · strength 0.19
  5. Sajid Ullah Khan · 1 shared paper, 2025 · strength 0.19
  6. Sanjeeb Kumar Sahoo · 1 shared paper, 2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.